Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

3 Pharmacy Stocks That Look Pretty Sickly

By Josh Enomoto, InvestorPlace Contributor

Pharmacies are struggling in the markets as sales and margins are being pressured in a highly competitive industry.

Can Alibaba Group Holding Ltd Rejuvenate BABA Stock Amid SEC Investigation?

By Josh Enomoto, InvestorPlace Contributor

Alibaba faces tough questions amid the ongoing SEC investigation, but longer-term challenges pose the real threat towards BABA stock.

Whole Foods Market, Inc. (WFM): Don’t Write Off “Whole Foods 365” Just Yet

By Josh Enomoto, InvestorPlace Contributor

The margin-friendly Whole Foods 365 concept will eat away at big-box retailers' revenue, potentially boosting value in WFM stock.

3 Stocks to Buy for Big Growth in Digital Payments – PYPL SQ MGI

By Josh Enomoto, InvestorPlace Contributor

Shares of digital payments companies have moved higher recently, but underlying fundamentals will take this area over the top. Paypal (PYPL), Square Inc (SQ) and Moneygram International (MGI) are three of the best ways to make a play on this trend.

3 Cancer-Fighting Stocks Making Waves in the Markets

By Josh Enomoto, InvestorPlace Contributor

After tripping up early in the year, cancer-fighting stocks JUNO, ECYT and SGEN are setting the stage for a comeback rally.

Load More